Sichuan Hebang Biotechnology Corporation Limited

SSE:603077.SS

1.69 (CNY) • At close April 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009
Operating Activities:
Net Income 1,278.6993,810.2393,031.3372.91506.611298.205505.192321.467238.732671.76364.429334.894366.276170.70643.223
Depreciation & Amortization 1,002.474929.598643.933642.951635.596575.121525.462417.595322.768268.706197.329195.228202.144153.72972.81
Deferred Income Tax 0-28.43897.641-47.91.6752.38930.471-14.952-10.265000000
Stock Based Compensation 0506.4850000000000000
Change In Working Capital -2,202.595-2,177.769-543.518-364.176-1,064.281-160.266-903.757-173.234-214.338-292.731-727.852-481.663-130.571-65.505-66.738
Accounts Receivables 690.169-1,083.05829.819-468.267-305.912145.014-726.084-94.524-225.486-143.448-371.896-185.019000
Inventory -2,349.41-1,178.601-278.928678.301-269.2076.276-193.68217.334125.911-353.435-99.547-220.171-65.493-80.771-9.647
Accounts Payables -624.134112.328-313.403-526.309-490.838-313.945-14.462-81.092-104.498000000
Other Working Capital 80.78-28.43818.994-47.91.675-166.542-710.075-190.568-340.24960.704-628.305-261.491-65.07715.266-57.091
Other Non Cash Items 122.181-395.85264.96687.1784.994231.33250.0489.429102.035-443.06458.61686.501114.71471.83619.672
Operating Cash Flow 200.7592,644.2633,196.718368.854162.92944.392176.944575.257449.197204.674-407.478134.96552.563330.76668.968
Investing Activities:
Investments In Property Plant And Equipment -828.735-936.181-1,735.052-197.093-662.544-363.565-508.534-677.445-1,130.474-716.769-598.534-273.828-345.165-571.005-848.527
Acquisitions Net 91.131417.905-2.414-643.9250.2382.15415.849-189.14115.102-255.9140345.16592.9620
Purchases Of Investments -165.0490-57.484-352.16-332.811-86.2-180.307-1,638.796-1200.002-1,050.0240-31.36-213.572-20
Sales Maturities Of Investments 120.42762.28651.822336.548280.474132.371,486.827109.926247.94627.4881,005.61430.2860.4260.6650
Other Investing Activites -120.42862.6530.3344.7482.428-3.15-4.7088.67-61.99662-0-0-345.1650.031-848.527
Investing Cash Flow -902.654-807.242-1,722.475-210.379-1,276.378-320.307795.433-2,181.797-1,253.666-612.177-898.858-243.542-376.105-630.919-868.527
Financing Activities:
Debt Repayment 147.11459.304-808285.226677.846243.24-327.07-2,336298416542-475.5193.5-46.9857.07
Common Stock Issued 0668.693179.928120.0722500000000000
Common Stock Repurchased -500.37-668.693-179.928-120.072-250-150000000000
Dividends Paid -392.632-130.877-77.981-92.742-71.102-253.247-110.227-198.392-378.728-214.961-273.766-123.315-121.253-126.062-147.232
Other Financing Activities -197.705743.506446.5466.03510.32-0.018-10.063,867.7411,307.35660.62-28.811,701.073-1.867240.764105.085
Financing Cash Flow -943.5971,004.984-619.36478.448367.065-160.025-447.3571,333.3491,226.628261.659239.4241,102.25870.3867.802814.922
Other Information:
Effect Of Forex Changes On Cash 5.46521.856-10.55426.2159.29336.053-23.21713.3616.910.474-0.085-0.017-0.354-0.234-0.002
Net Change In Cash -1,640.0262,863.86844.326263.138-737.1500.113501.803-259.83429.069-145.37-1,066.997993.659246.483-232.58515.36
Cash At End Of Period 2,904.8324,544.8581,680.998836.672573.5341,310.634810.52308.717568.547139.478284.8481,351.845358.186111.703344.288